ArticleJournal of animal science2025
Vitamin D₃ inhibits proliferation and the early stage of adipogenic differentiation but promotes gene expression and lipid accumulation during the late stage of adipogenic differentiation in intramuscular adipose cells of Korean native cattle.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the role of 1,25-dihydroxyvitamin D₃ (vitamin D₃) in regulating adipogenesis in stromal vascular (SV) cells derived from Korean native cattle (Hanwoo), focusing on its dose- (0, 1, 10, and 100 nM) and time-dependent effects across the growth phase and the early(day 3), mid (day 7), and late (day 14) stages of the differentiation phase. SV cells were isolated from the intramuscular fat of the Longissimus thoracis muscle of four female Hanwoo cattle (29 to 32 mo old) raised on the same farm. Vitamin D₃ treatment during the growth phase significantly suppressed preadipocyte proliferation in a dose-dependent manner. Hyperplasia was significantly reduced at 10 and 100 nM of treatment compared to the control group (P < 0.01). During the early differentiation phase, high concentrations of vitamin D₃ (10 and 100 nM) delayed differentiation by suppressing the expression of Zfp423 and PPARγ, key transcription factors involved in preadipocyte determination and commitment (P < 0.05). In the mid-differentiation phase, 10 and 100 nM of vitamin D₃ significantly upregulated the expression of FABP4 and PPARγ compared to the control (P < 0.01), while no significant differences were observed in lipid accumulation or droplet size. In the late differentiation phase, 10 nM significantly increased the expression of PPARγ and FABP4 compared to the control group (P < 0.01), while enhanced lipid accumulation was observed at 1 and 10 nM of treatment (P < 0.01). Notably, lipid droplet size was significantly increased only at 1 nM compared to all other treatments (P < 0.01). These findings demonstrate the dual role of vitamin D₃ in adipogenesis. During the growth phase, vitamin D₃ inhibits hyperplasia by suppressing preadipocyte proliferation in a dose-dependent manner. During the differentiation phase, vitamin D₃ exhibits stage-specific effects, delaying differentiation in the early phase while promoting adipocyte maturation in the late phase through enhanced lipid accumulation and hypertrophy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.